Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0840-5, published online 27 April 2020.
In the version of this article initially published, the label ‘TPS1 ≥ 1%’ in the top left box of Fig. 1a was incorrect. The correct label is ‘TPS ≥ 1%'. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, Y., Xue, J., Deng, T. et al. Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat Med 26, 1149 (2020). https://doi.org/10.1038/s41591-020-0973-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-0973-6
This article is cited by
-
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
Journal of Translational Medicine (2022)
